Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 164

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Fecal transplantation for treatment of inflammatory bowel disease

Open access
Imdad, Aamer, Nicholson, Maribeth R, Tanner-Smith, Emily E, Zackular, Joseph P, Gomez-Duarte, Oscar G, Beaulieu, Dawn B, Acra, Sari · 2018 · Cochrane Database of Systematic Reviews

Abstract

versus control for participants with ulcerative colitis, Outcome 17 Endoscopic response at 8 weeks..

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd012774.pub2

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Research works printed but not linked: 66

  1. Costello, 2017, Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild moderately active ulcerative colitis: a randomised controlled trial, Journal of Crohn's and Colitis, 11, S23, 10.1093/ecco-jcc/jjx002.035 · DOI
  2. Moayyedi, 2014, A randomized, placebo controlled trial of fecal microbiota therapy in active ulcerative colitis, Gastroenterology, 146, S, 10.1016/S0016-5085(14)60567-9 · DOI
  3. Paramsothy, 2016, Multi donor intense faecal microbiota transplantation is an effective treatment for resistant ulcerative colitis: A randomised placebo-controlled trial, Gastroenterology, 150, S122, 10.1016/S0016-5085(16)30517-0 · DOI
  4. Paramsothy S Kamm MA Walsh AJ Bogaerde J Samuel D Leong RWL Multi donor intense faecal microbiota transplantation is an effective treatment for resistant ulcerative colitis: a randomised placebo controlled trial and microbiota analysis Journal of Gastroenterology and Hepatology 2016 143 · DOI
  5. Fuentes, 2017, Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation, ISME Journal, 11, 1877, 10.1038/ismej.2017.44 · DOI · Paper page
  6. Allegretti, 2016, Irregular bowel movements following fecal microbiota transplantation (FMT) are associated with pre-existing irritable bowel syndrome but not FMT-related factors, Gastroenterology, 150, S742, 10.1016/S0016-5085(16)32519-7 · doi:10.1016/s0016-5085(16)32519-7
  7. Borody, 2003, Treatment of ulcerative colitis using fecal bacteriotherapy, Journal of Clinical Gastroenterology, 37, 42, 10.1097/00004836-200307000-00012 · DOI · Paper page
  8. Chin, 2017, Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: A Single-Center Experience, Clinical Gastroenterology & Hepatology, 15, 597, 10.1016/j.cgh.2016.11.028 · DOI
  9. Fischer, 2016, Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease, Inflammatory Bowel Diseases, 22, 2402, 10.1097/MIB.0000000000000908 · DOI · Paper page
  10. Gionchetti, 2000, Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial, Gastroenterology, 119, 305, 10.1053/gast.2000.9370 · DOI · Paper page
  11. Hourigan, 2015, Microbiome changes associated with sustained eradication of clostridium difficile after fecal microbiota transplantation in children with and without inflammatory bowel disease, Gastroenterology, S45, 10.1016/S0016-5085(15)30157-8 · DOI
  12. Ishikawa, 2017, Changes in intestinal microbiota following combination therapy with fecal microbial transplantation and antibiotics for ulcerative colitis, Inflammatory Bowel Diseases, 23, 116, 10.1097/MIB.0000000000000975 · DOI
  13. Mandalia, 2016, Fecal transplant is as effective and safe in immunocompromised as non-immunocompromised patients for Clostridium difficile, International Journal of Colorectal Disease, 31, 1059, 10.1007/s00384-015-2396-2 · DOI
  14. Mintz, 2016, Comparing fecal microbial transplant outcomes in patients with recurrent clostridium difficile or ulcerative colitis, Inflammatory Bowel Diseases, 22, S31, 10.1097/01.MIB.0000480184.07677.0e · doi:10.1097/01.mib.0000480184.07677.0e
  15. Wei, 2016, Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora, BMC Microbiology, 16, 255, 10.1186/s12866-016-0869-2 · DOI
  16. NCT01961492, Fecal Microbiota Transplantation in Patients with Ulcerative Colitis, clinicaltrials.gov/ct2/show/NCT01961492
  17. Pai, 2017, Protocol for a randomised, placebo-controlled pilot study for assessing feasibility and efficacy of faecal microbiota transplantation in a paediatric ulcerative colitis population: PediFETCh trial, BMJ Open, 7, 1, 10.1136/bmjopen-2017-016698 · DOI
  18. Pai, 2016, A randomized, placebo-controlled trial of fecal microbial transplantation for pediatric ulcerative colitis (pedifetch trial), Journal of Pediatric Gastroenterology and Nutrition, 63, S79
  19. NCT03104036, Faecal Bacteriotherapy for Ulcerative Colitis (FACTU), clinicaltrials.gov/ct2/show/NCT03104036
  20. Abraham, 2012, Natural history of pediatric-onset inflammatory bowel disease: a systematic review, Journal of Clinical Gastroenterology, 46, 581, 10.1097/MCG.0b013e318247c32f · DOI · Paper page
  21. Ahuja, 2010, Inflammatory bowel disease in the Asia-Pacific area: a comparison with developed countries and regional differences, Journal of Digestive Diseases, 11, 134, 10.1111/j.1751-2980.2010.00429.x · DOI · Paper page
  22. Alang, 2015, Weight gain after fecal microbiota transplantation, Open Forum Infectious Diseases, 2, ofv004, 10.1093/ofid/ofv004 · DOI · Paper page
  23. Armuzzi, 2012, Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel disease, Journal of Crohn's & Colitis, 6, 492, 10.1016/j.crohns.2011.12.016 · DOI
  24. Assa, 2016, Mucosa-Associated Ileal Microbiota in New-Onset Pediatric Crohn's Disease, Inflammatory Bowel Diseases, 22, 1533, 10.1097/MIB.0000000000000776 · DOI
  25. Austin, 2014, Fecal microbiota transplantation in the treatment of Clostridium difficile infections, American Journal of Medicine, 127, 479, 10.1016/j.amjmed.2014.02.017 · DOI
  26. Auzoux, 2016, Assessment of Mucosal Healing in Inflammatory Bowel Disease, Journal of Clinical Gastroenterology and Hepatology, 1, 1
  27. Bejaoui, 2015, Targeting the Microbiome in Inflammatory Bowel Disease: Critical Evaluation of Current Concepts and Moving to New Horizons, Digestive Diseases, 33, 105, 10.1159/000437104 · DOI
  28. Cammarota, 2015, Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection, Alimentary Pharmacology & Therapeutics, 41, 835, 10.1111/apt.13144 · DOI · Paper page
  29. Carding, 2017, Review article: the human intestinal virome in health and disease, Alimentary Pharmacology & Therapeutics, 46, 800, 10.1111/apt.14280 · DOI · Paper page
  30. Cleynen I Boucher G Jostins L Schumm LP Zeissig S Ahmad T Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study Lancet 2016 156 67 · DOI · Paper page
  31. Colman, 2014, Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis, Journal of Crohn's & Colitis, 8, 1569, 10.1016/j.crohns.2014.08.006 · DOI · Paper page
  32. Costello, 2017, Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis, Alimentary Pharmacology & Therapeutics, 46, 213, 10.1111/apt.14173 · DOI · Paper page
  33. Dahlhamer, 2016, Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥ 18 Years - United States, 2015, MMWR. Morbidity and Mortality Weekly Report, 65, 1166, 10.15585/mmwr.mm6542a3 · DOI · Paper page
  34. Dave, 2012, Mucosal healing in inflammatory bowel disease-a true paradigm of success?, Gastroenterology and Hepatology, 8, 29
  35. Preter, 2012, Decreased mucosal sulfide detoxification is related to an impaired butyrate oxidation in ulcerative colitis, Inflammatory Bowel Diseases, 18, 2371, 10.1002/ibd.22949 · DOI · Paper page
  36. Dulai, 2015, Assessment of mucosal healing in inflammatory bowel disease: review, Gastrointestinal Endoscopy, 82, 246, 10.1016/j.gie.2015.03.1974 · DOI
  37. Feakins, 2013, Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines, Journal of Clinical Pathology, 66, 1005, 10.1136/jclinpath-2013-201885 · DOI · Paper page
  38. Fuentes, 2017, Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation, ISME Journal, 11, 1877, 10.1038/ismej.2017.44 · DOI · Paper page
  39. Hozo, 2005, Estimating the mean and variance from the median, range, and the size of a sample, BMC Medical Research Methodology, 20, 13, 10.1186/1471-2288-5-13 · DOI · Paper page
  40. Kelly, 2014, Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients, American Journal of Gastroenterology, 109, 1065, 10.1038/ajg.2014.133 · DOI · Paper page
  41. Kelly CR Khoruts A Staley C Sadowsky MJ Abd M Alani M Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial Annals of Internal Medicine 2016 609 16 · DOI · Paper page
  42. Khoruts, 2016, Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection, Clinical Gastroenterology & Hepatology, 14, 1433, 10.1016/j.cgh.2016.02.018 · DOI · Paper page
  43. Kostic, 2014, The microbiome in inflammatory bowel disease: current status and the future ahead, Gastroenterology, 146, 1489, 10.1053/j.gastro.2014.02.009 · DOI · Paper page
  44. Leffler, 2015, Clostridium difficile infection, New England Journal of Medicine, 372, 1539, 10.1056/NEJMra1403772 · DOI · Paper page
  45. Link, 2016, Endoscopic peroral jejunal fecal microbiota transplantation, Digestive & Liver Disease, 48, 1336, 10.1016/j.dld.2016.08.110 · DOI
  46. Mallon, 2007, Probiotics for induction of remission in ulcerative colitis, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD005573.pub2 · DOI · Paper page
  47. Mehta, 2016, Report: economic implications of inflammatory bowel disease and its management, American Journal of Managed Care, 22, s51
  48. Molodecky, 2012, Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review, Gastroenterology, 142, 46, 10.1053/j.gastro.2011.10.001 · DOI · Paper page
  49. Morgan, 2012, Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment, Genome Biology, 13, R79, 10.1186/gb-2012-13-9-r79 · DOI · Paper page
  50. Mowat C Cole A Windsor A Ahmad T Arnott I Driscoll R Guidelines for the management of inflammatory bowel disease in adults Gut 2011 571 607 · DOI · Paper page
  51. Nagao-Kitamoto, 2016, Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice, Cellular and Molecular Gastroenterology and Hepatology, 2, 468, 10.1016/j.jcmgh.2016.02.003 · DOI · Paper page
  52. Naidoo, 2011, Probiotics for maintenance of remission in ulcerative colitis, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD007443.pub2 · DOI
  53. Osman, 2016, Donor Efficacy in Fecal Microbiota Transplantation for Recurrent Clostridium difficile: Evidence From a 1,999-Patient Cohort, Open Forum Infectious Diseases, 3, 841, 10.1093/ofid/ofw194.48 · DOI
  54. Owens, 2013, Fecal microbiota transplantation and donor standardization, Trends in Microbiology, 21, 443, 10.1016/j.tim.2013.07.003 · DOI
  55. Petersen, 2014, Defining dysbiosis and its influence on host immunity and disease, Cellular Microbiology, 16, 1024, 10.1111/cmi.12308 · DOI · Paper page
  56. Peyrin-Biroulet, 2011 Oct, Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease, Journal of Crohn's & Colitis, 5, 477, 10.1016/j.crohns.2011.06.009 · DOI · Paper page
  57. Rapozo, 2017, Diet and microbiota in inflammatory bowel disease: The gut in disharmony, World Journal of Gastroenterology, 23, 2124, 10.3748/wjg.v23.i12.2124 · DOI · Paper page
  58. The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014
  59. Schulberg, 2016, Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease, Internal Medicine Journal, 46, 266, 10.1111/imj.13003 · DOI
  60. Shi, 2016, Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis, PLoS One, 11, e0157259, 10.1371/journal.pone.0157259 · DOI
  61. Singh, 2015, Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001176.pub3 · DOI · Paper page
  62. Solari, 2014, Tempered enthusiasm for fecal transplant, Clinical Infectious Diseases, 59, 319, 10.1093/cid/ciu278 · DOI
  63. Sun, 2016, Fecal Microbiota Transplantation as a Novel Therapy for Ulcerative Colitis: A Systematic Review and Meta-Analysis, Medicine, 95, e3765, 10.1097/MD.0000000000003765 · DOI
  64. Vindigni, 2016, The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions, Therapeutic Advances in Gastroenterology, 9, 606, 10.1177/1756283X16644242 · DOI · Paper page
  65. Weintraub, 2014, Temporal trends in inflammatory bowel disease publications over a 19-years period, World Journal of Gastroenterology, 20, 16745, 10.3748/wjg.v20.i44.16745 · doi:10.3748/wjg.v20.i44.16745
  66. Witherden, 2017, The Human Mucosal Mycobiome and Fungal Community Interactions, Journal of Fungi, 3, 56, 10.3390/jof3040056 · DOI

Cited by

See all 164

Metadata

Authors
Imdad, A., Nicholson, M. R., Tanner-Smith, E. E., Zackular, J. P., Gomez-Duarte, O. G., Beaulieu, D. B., & Acra, S.
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2018-11-13
Volume
2018
Issue
11
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W4255727347
Cited by
164
References
21
FWCI
12.35
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fecal transplantation for treatment of inflammatory bowel disease. https://app.cochat.ai/papers/10.1002/14651858.cd012774.pub2
The paper
Imdad, A., Nicholson, M. R., Tanner-Smith, E. E., Zackular, J. P., Gomez-Duarte, O. G., Beaulieu, D. B., & Acra, S. (2018). Fecal transplantation for treatment of inflammatory bowel disease. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd012774.pub2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.